Aukštaitijos implantologijos klinika, UAB - financials and debts
Company age: 12 y. 6 mo.
Aukštaitijos implantologijos klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 715,814 | 1,269,971 | 1,378,536 | 2,150,163 | 2,373,899 | 2,587,226 | 2,950,641 | 3,172,731 |
| Profit before tax | - | 267,600 | 204,536 | 553,960 | 412,000 | 30,126 | -66,297 | -173,743 |
| Net profit | 79,799 | 223,794 | 172,534 | 472,898 | 349,780 | 23,867 | -66,297 | -173,743 |
| Equity | 82,985 | 226,989 | 175,729 | 511,059 | 402,778 | 78,865 | 12,569 | -161,175 |
| Liabilities | 86,691 | 103,519 | 132,936 | 199,290 | 289,735 | 368,291 | 454,586 | 568,620 |
| Non-current assets | 37,612 | 30,471 | 35,479 | 49,573 | 89,518 | 50,721 | 15,516 | 318 |
| Current assets | 131,182 | 299,466 | 276,456 | 659,055 | 601,647 | 412,403 | 460,201 | 407,191 |
| Total assets | 168,794 | 329,937 | 311,935 | 708,628 | 691,165 | 463,124 | 475,717 | 407,509 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 374,952 | 338,217 | 364,083 |
| Social insurance contributions | - | - | - | - | - | 259,675 | 320,665 | 349,545 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +9.6% | +77.4% | +8.5% | +56.0% | +10.4% | +9.0% | +14.0% | +7.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 47.3% | 67.8% | 55.3% | 66.7% | 50.6% | 5.2% | -13.9% | -42.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 96.2% | 98.6% | 98.2% | 92.5% | 86.8% | 30.3% | -527.5% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 11.1% | 17.6% | 12.5% | 22.0% | 14.7% | 0.9% | -2.2% | -5.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | 21.1% | 14.8% | 25.8% | 17.4% | 1.2% | -2.2% | -5.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.0 | 0.5 | 0.8 | 0.4 | 0.7 | 4.7 | 36.2 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 36,866 | 56,028 | 45,446 | 63,866 | 72,302 | 76,282 | 71,531 | 77,858 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Aukštaitijos implantologijos klinika - Social security debts
The company had no debts to Sodra
Aukštaitijos implantologijos klinika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-05-01 | 2026-05-26 | 1.46 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Aukštaitijos implantologijos klinika, UAB is a Private Limited Liability Company (code 303254010) operating in dental practice care activities. In the latest financial year, 2025, revenue increased to €3.17M, up 7.5% year on year and 22.6% over two years. Despite the stronger top line, profitability weakened further: net profit fell to a loss of €173.7K, compared with a loss of €66.3K in 2024 and a profit of €23.9K in 2023. The 2025 profit margin was -5.5%. The balance sheet also deteriorated, with total assets decreasing to €407.5K from €475.7K a year earlier, while liabilities rose to €568.6K and equity turned negative at -€161.2K. Long-term assets were minimal at €318, and short-term assets made up almost all assets at €407.2K. Asset turnover remained high at 7.79x, and revenue per employee was €79.3K, while profit per employee was -€4.3K. Given the negative equity base, return and leverage ratios should be interpreted cautiously, as they reflect a strained capital structure in 2025.